Technology | 2009.09.23
TRADE NEWS: Agilent Technologies Adds Human Exon Kit to Next-Generation-Sequencing Target Enrichment Portfolio
PROVIDENCE, R.I.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) has chosen the Cambridge Health Institute’s Next-Generation Sequencing Analysis conference today to introduce its SureSelect Human All Exon Kit for target enrichment prior to next-generation DNA sequencing. This catalog kit extends the efficiency and cost-effectiveness of the SureSelect Target Enrichment System to studies of all human exons, a region totaling approximately 38 Mb. Available next month, the kit is offered
For more information, please visit
http://www.businesswire.com/news/home/20090922005402/en
